Dentsply Sirona Appoints Richard Rosenzweig as Senior Vice President, Corporate Development, General Counsel and Secretary

Richard Rosenzweig is a strategic and business-minded Executive with both commercial and enterprise focus, diverse leadership experience and a 25-year history advising global health care companies. Mr. Rosenzweig joins from AngioDynamics where he led the legal department (including compliance) and served as Secretary to the Board as Senior Vice President, General Counsel & Secretary.

Simon Campion, Chief Executive Officer of Dentsply Sirona, said, “We are pleased to have Richard with his diverse leadership experience and a 25-year track record in healthcare join us. As a strong, collaborative leader with seasoned skills in building teams and setting and executing strategies, he will strengthen our Management Team during a phase of organizational changes. Richard adds valuable additional experience with his record of delivering excellent results, including in complex strategic initiatives, transactions and disputes. He also brings critical in-depth governance & compliance expertise.”

Richard Rosenzweig said, “It’s an honor to join Dentsply Sirona as a leading healthcare company and global leader in the dental industry. I share the same values and I am convinced that with the strong team, operational excellence, and a strong focus on accountability we can unlock the full potential of Dentsply Sirona globally. I look forward to partnering with the Management Team on the important mission to transform dentistry to improve oral health globally.”

About Richard Rosenzweig

Most recently, Richard Rosenzweig served as Senior Vice President, General Counsel & Secretary at AngioDynamics where he led the legal department including compliance and served as Secretary to the Board for this publicly traded medical device company. Previously, he held several roles during his more than ten years at C. R. Bard Inc., including serving as Vice President, Law & Assistant Secretary, and being a Member of the Corporate Management Committee. Other previous experiences include General Counsel roles at other public companies and a leading role at Johnson & Johnson. He is a member of the Director’s Leadership Council at Rutgers Biomedical and Health Sciences and has served as a member of the Rutgers Cancer Institute of New Jersey Director’s Leadership Counsel for 15 years. Richard earned his law degree from Boston University School of Law and holds a Bachelor of Arts, Psychology, from Brandeis University.

DISCLAIMER

This information and any attachment thereto contains “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements are not guarantees of future performance. These forward-looking statements reflect views and assumptions regarding expectations and projections about future events and are based on currently available information or information available on the date of any document incorporated by reference. You can generally identify these forward-looking statements by the use of words such as "may," "could," "estimate," "will," "believe," "anticipate," "think," "intend," "expect," "project," "plan," "target," "forecast", and similar words and expressions. However, these words are not the exclusive means of identifying such statements. In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances are forward-looking statements and may include statements relating to future revenues, expenses, margins, profitability, net income/(loss), earnings per share and other measures of results of operations and the prospects of future growth of our business. These forward-looking statements are inherently subject to uncertainties, risks and changes in circumstances that are difficult to predict. For a discussion of such risks, uncertainties and other matters that could cause actual results to differ materially, including risks relating to, among other factors, the market for dental products and services, pricing, future sales volume of the Company’s products, the possibility of changing economic, market and competitive conditions, dependence on products, dependence on key personnel, technological developments, intense competition, market uncertainties, dependence on distributors, ability to manage growth, dependence on key suppliers, dependence on key members of management, government regulation, our ability to integrate the businesses of Dentsply Sirona, acquisitions and affiliations, readers are urged to carefully review and consider various disclosures made by the Company and Dentsply Sirona in their public filings, including in their Annual Reports on Form 10-K and in their reports on Forms 10-Q and 8-K filed with the Securities and Exchange Commission.

Readers are cautioned not to place undue reliance on such statements, which speak only as of the date hereof. Except as required by law, the Company does not assume any obligation to update any forward-looking statements contained in this document or the attachments to reflect new information or future events or developments after the date any such statement is made.